FDA pivotal clinical study of PRK with the ALLEGRETTO WAVE EYE-Q (2016)
U.S. Food and Drug Administration
Excimer laser system
Alcon Laboratories, Inc. ALLEGRETTO WAVE EYE-Q
Excimer laser system evaluated for photorefractive keratectomy in the FDA pivotal study.
1studies represented
320enrolled eyes
1study arms
1 yearlongest standardized follow-up